Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.
Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to include 13 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.5%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check32 days agoChange DetectedThe value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus Genetics related topics: Lung cancer Drug Information available for: Durvalumab FDA Drug and Device Resources' in the webpage.SummaryDifference44%
Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.